- Report
- April 2024
- 1800 Pages
Global
From €3880EUR$3,995USD£3,315GBP
- Report
- March 2024
- 197 Pages
Global
From €3277EUR$3,374USD£2,800GBP
€3641EUR$3,749USD£3,111GBP
- Report
- March 2024
- 190 Pages
Global
From €3277EUR$3,374USD£2,800GBP
€3641EUR$3,749USD£3,111GBP
- Report
- September 2023
- 249 Pages
Global
From €4785EUR$5,100USD£3,950GBP
- Report
- June 2023
- 186 Pages
Global
From €5342EUR$5,500USD£4,564GBP
- Report
- February 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,149GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,149GBP
- Report
- February 2024
- 150 Pages
Global
From €5779EUR$5,950USD£4,937GBP
- Report
- January 2024
- 150 Pages
Global
From €4710EUR$4,850USD£4,024GBP
- Report
- March 2024
- 186 Pages
Global
From €3277EUR$3,374USD£2,800GBP
€3641EUR$3,749USD£3,111GBP
- Report
- August 2023
- 240 Pages
Global
From €1933EUR$1,990USD£1,651GBP
- Report
- April 2024
- 93 Pages
Global
From €5439EUR$5,600USD£4,647GBP
- Report
- September 2023
- 140 Pages
Global
From €5779EUR$5,950USD£4,937GBP
- Report
- August 2023
- 150 Pages
Global
From €5779EUR$5,950USD£4,937GBP
- Report
- June 2023
- 180 Pages
Global
From €5779EUR$5,950USD£4,937GBP
- Report
- April 2024
Global
From €2865EUR$2,950USD£2,448GBP
- Report
- April 2024
Global
From €1894EUR$1,950USD£1,618GBP
- Report
- May 2023
- 142 Pages
Global
From €2427EUR$2,499USD£2,074GBP
- Report
- February 2024
- 75 Pages
Global
From €4808EUR$4,950USD£4,107GBP
- Report
- November 2023
- 78 Pages
Global
From €2380EUR$2,450USD£2,033GBP
The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy.
The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes.
The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more